196 related articles for article (PubMed ID: 14978418)
1. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
[TBL] [Abstract][Full Text] [Related]
3. Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane.
Bernitsas E; Wei W; Mikol DD
Ann Neurol; 2006 Jan; 59(1):206-9. PubMed ID: 16374818
[TBL] [Abstract][Full Text] [Related]
4. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
[TBL] [Abstract][Full Text] [Related]
5. Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis.
Zingler VC; Nabauer M; Jahn K; Gross A; Hohlfeld R; Brandt T; Strupp M
Eur Neurol; 2005; 54(1):28-33. PubMed ID: 16088176
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
Hamzehloo A; Etemadifar M
Arch Iran Med; 2006 Apr; 9(2):111-4. PubMed ID: 16649351
[TBL] [Abstract][Full Text] [Related]
7. Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
Killestein J; van der Meer ML; Regelink JC; Huijgens PC; Polman CH
Neurology; 2010 Mar; 74(11):934; author reply 934. PubMed ID: 20231672
[No Abstract] [Full Text] [Related]
8. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapy of multiple sclerosis with mitoxantrone].
Mauch E; Kornhuber HH
Fortschr Neurol Psychiatr; 1993 Dec; 61(12):410-7. PubMed ID: 8112704
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.
Zecca C; Petrini L; Limoni C; Staedler C; Gobbi C
Eur Neurol; 2011; 65(1):40-5. PubMed ID: 21196739
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Le Page E; Leray E; Edan G;
Mult Scler; 2011 Jul; 17(7):867-75. PubMed ID: 21325016
[TBL] [Abstract][Full Text] [Related]
12. [Mitoxantrone].
Pericot I; Montalban X
Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
Neuhaus O; Kieseier BC; Hartung HP
Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
[TBL] [Abstract][Full Text] [Related]
14. Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Goffette S; van Pesch V; Vanoverschelde JL; Morandini E; Sindic CJ
J Neurol; 2005 Oct; 252(10):1217-22. PubMed ID: 15834643
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
Ko MW; Tamhankar MA; Volpe NJ; Porter D; McGrath C; Galetta SL
J Neurol Sci; 2008 Oct; 273(1-2):144-7. PubMed ID: 18687447
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic role of mitoxantrone in multiple sclerosis.
Neuhaus O; Kieseier BC; Hartung HP
Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone-related acute leukemia in two MS patients.
Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
Sumrall A; Dreiling B
J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
[TBL] [Abstract][Full Text] [Related]
20. [Mitoxantrone for the treatment of patients with multiple sclerosis].
Komori M; Kondo T; Tanaka M
Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
